Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial Hypertension.


Journal

Circulation. Heart failure
ISSN: 1941-3297
Titre abrégé: Circ Heart Fail
Pays: United States
ID NLM: 101479941

Informations de publication

Date de publication:
10 2023
Historique:
pmc-release: 01 10 2024
medline: 23 10 2023
pubmed: 4 9 2023
entrez: 4 9 2023
Statut: ppublish

Résumé

Normative changes in right ventricular (RV) structure and function have not been characterized in the context of treatment-associated functional recovery (RV functional recovery [RVFnRec]). The aim of this study is to assess the clinical relevance of a proposed RVFnRec definition. We evaluated 63 incident patients with pulmonary arterial hypertension by right heart catheterization and cardiac magnetic resonance imaging at diagnosis and cardiac magnetic resonance imaging and invasive cardiopulmonary exercise testing following treatment (≈11 months). Sex, age, ethnicity matched healthy control subjects (n=62) with 1-time cardiac magnetic resonance imaging and noninvasive cardiopulmonary exercise testing were recruited from the PVDOMICS (Redefining Pulmonary Hypertension through Pulmonary Vascular Disease Phenomics) project. We examined therapeutic cardiac magnetic resonance imaging changes relative to the evidence-based peak oxygen consumption (VO A drop in RV end-diastolic volume of -15 mL best defined RVFnRec (area under the curve, 0.87; RVFnRec defined by RV end-diastolic volume therapeutic decrease of -15 mL predicts exercise capacity, freedom from clinical worsening, and nears normalization. A therapeutic improvement of compliance is superior to other measures of afterload in predicting RVFnRec. RVFnRec is also associated with increased RV output reserve at exercise.

Sections du résumé

BACKGROUND
Normative changes in right ventricular (RV) structure and function have not been characterized in the context of treatment-associated functional recovery (RV functional recovery [RVFnRec]). The aim of this study is to assess the clinical relevance of a proposed RVFnRec definition.
METHODS
We evaluated 63 incident patients with pulmonary arterial hypertension by right heart catheterization and cardiac magnetic resonance imaging at diagnosis and cardiac magnetic resonance imaging and invasive cardiopulmonary exercise testing following treatment (≈11 months). Sex, age, ethnicity matched healthy control subjects (n=62) with 1-time cardiac magnetic resonance imaging and noninvasive cardiopulmonary exercise testing were recruited from the PVDOMICS (Redefining Pulmonary Hypertension through Pulmonary Vascular Disease Phenomics) project. We examined therapeutic cardiac magnetic resonance imaging changes relative to the evidence-based peak oxygen consumption (VO
RESULTS
A drop in RV end-diastolic volume of -15 mL best defined RVFnRec (area under the curve, 0.87;
CONCLUSIONS
RVFnRec defined by RV end-diastolic volume therapeutic decrease of -15 mL predicts exercise capacity, freedom from clinical worsening, and nears normalization. A therapeutic improvement of compliance is superior to other measures of afterload in predicting RVFnRec. RVFnRec is also associated with increased RV output reserve at exercise.

Identifiants

pubmed: 37664964
doi: 10.1161/CIRCHEARTFAILURE.123.010555
pmc: PMC10592283
mid: NIHMS1920904
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e010555

Subventions

Organisme : NHLBI NIH HHS
ID : U01 HL125218
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL125175
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL125205
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL125177
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL125215
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL125208
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL125212
Pays : United States

Commentaires et corrections

Type : UpdateOf

Références

J Heart Lung Transplant. 2019 Mar;38(3):306-314
pubmed: 30581051
J Heart Lung Transplant. 2017 Oct 2;:
pubmed: 29107544
Am J Respir Crit Care Med. 2010 Jul 15;182(2):252-60
pubmed: 20339143
Eur Respir J. 2019 Jan 24;53(1):
pubmed: 30545968
Circulation. 2013 Oct 29;128(18):2005-15
pubmed: 24056689
Circ Heart Fail. 2021 Jun;14(6):
pubmed: 34422205
J Am Coll Cardiol. 2022 Aug 16;80(7):697-718
pubmed: 35953136
J Cardiol. 2017 Jan;69(1):182-188
pubmed: 27012754
Eur Respir J. 2017 Aug 24;50(2):
pubmed: 28838981
J Appl Physiol (1985). 2021 Jul 1;131(1):424-433
pubmed: 34043473
Int J Cardiol. 2017 Mar 1;230:53-58
pubmed: 28038821
Eur Heart J. 2022 Oct 11;43(38):3618-3731
pubmed: 36017548
Am J Respir Crit Care Med. 2013 Mar 15;187(6):576-83
pubmed: 23348976
Cardiovasc Res. 1992 Sep;26(9):839-44
pubmed: 1451160
Chest. 2019 Aug;156(2):323-337
pubmed: 30772387
J Am Coll Cardiol. 2017 Jan 17;69(2):236-243
pubmed: 28081831
Eur Respir J. 2017 Nov 22;50(5):
pubmed: 29167297
J Cardiovasc Magn Reson. 2020 Dec 14;22(1):87
pubmed: 33308262
J Heart Lung Transplant. 2015 Mar;34(3):395-403
pubmed: 25499139
J Heart Lung Transplant. 2015 Oct;34(10):1334-45
pubmed: 26087665
Am J Respir Crit Care Med. 2020 Feb 15;201(4):458-468
pubmed: 31647310
Circ Cardiovasc Imaging. 2014 Jan;7(1):107-14
pubmed: 24173272
JACC Cardiovasc Imaging. 2020 Sep;13(9):2054-2056
pubmed: 32563644
Am J Physiol Lung Cell Mol Physiol. 2018 Mar 1;314(3):L443-L460
pubmed: 29097426
Circ Cardiovasc Imaging. 2016 Mar;9(3):e003810
pubmed: 26962126
JACC Cardiovasc Imaging. 2012 Apr;5(4):378-87
pubmed: 22498327
Circ Heart Fail. 2020 Mar;13(3):e006363
pubmed: 32088984
Chest. 2022 Apr;161(4):1048-1059
pubmed: 34637777
J Am Coll Cardiol. 2011 Feb 22;57(8):921-8
pubmed: 21329838
Eur Respir Rev. 2010 Sep;19(117):197-203
pubmed: 20956192
Circulation. 1992 Aug;86(2):513-21
pubmed: 1638719
Interact Cardiovasc Thorac Surg. 2017 Jun 1;24(6):890-897
pubmed: 28329267
Ann Am Thorac Soc. 2016 Feb;13(2):276-84
pubmed: 26848601
Am J Respir Crit Care Med. 2022 Apr 1;205(7):751-760
pubmed: 34905704
Am J Respir Crit Care Med. 2018 Aug 15;198(4):e15-e43
pubmed: 30109950
Chest. 2016 Feb;149(2):353-361
pubmed: 26134583
Chest. 2020 Feb;157(2):376-383
pubmed: 31563498
Rheumatology (Oxford). 2009 Sep;48(9):1137-42
pubmed: 19605369
Eur Respir J. 2015 Oct;46(4):903-75
pubmed: 26318161
Circ Heart Fail. 2020 May;13(5):e007081
pubmed: 32408812
Eur Respir J. 2017 Jun 29;49(6):
pubmed: 28663315
Heart. 2017 Mar;103(6):421-427
pubmed: 27566296
Eur Heart J. 2008 Jan;29(1):120-7
pubmed: 18065750
JACC Cardiovasc Imaging. 2022 Feb;15(2):240-253
pubmed: 34801462
Eur Respir J. 2014 Sep;44(3):704-13
pubmed: 24833765
Circulation. 2018 May 29;137(22):2360-2370
pubmed: 29352073
Cardiovasc Res. 2020 Aug 1;116(10):1700-1709
pubmed: 31738411
Pulm Circ. 2015 Jun;5(2):291-5
pubmed: 26064453
J Am Heart Assoc. 2014 Jun 03;3(3):e000716
pubmed: 24895160
Circulation. 2011 Jun 7;123(22):2542-51
pubmed: 21646505

Auteurs

Franz P Rischard (FP)

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine (F.P.R., M.I.), University of Arizona, Tuscon.

Roberto J Bernardo (RJ)

Division of Pulmonary, Critical Care and Sleep Medicine, University of Oklahoma Health Sciences Center, Oklahoma City (R.J.B.).

Rebecca R Vanderpool (RR)

Division of Cardiovascular Medicine, The Ohio State University, Columbus (R.R.V.).

Deborah H Kwon (DH)

Department of Cardiovascular Medicine (D.H.K., M.M.P., W.H.W.T.), Cleveland Clinic, Cleveland, OH.

Tushar Acharya (T)

Divison of Cardiology (T.A., S.K.), University of Arizona, Tuscon.

Margaret M Park (MM)

Department of Cardiovascular Medicine (D.H.K., M.M.P., W.H.W.T.), Cleveland Clinic, Cleveland, OH.

Austin Katrynuik (A)

Department of Medicine (A.K., J.G.N.G.), University of Arizona, Tuscon.

Michael Insel (M)

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine (F.P.R., M.I.), University of Arizona, Tuscon.

Saad Kubba (S)

Divison of Cardiology (T.A., S.K.), University of Arizona, Tuscon.

Roberto Badagliacca (R)

Department of Cardiovascular and Respiratory Science, Sapienza University of Rome, Italy (R.B.).

A Brett Larive (AB)

Department of Quantitative Health Sciences (A.B.L., G.J.B.), Cleveland Clinic, Cleveland, OH.

Robert Naeije (R)

Department of Pathophysiology, Free University of Brussels, Belgium (R.N.).

Joe G N Garcia (JGN)

Department of Medicine (A.K., J.G.N.G.), University of Arizona, Tuscon.

Gerald J Beck (GJ)

Department of Quantitative Health Sciences (A.B.L., G.J.B.), Cleveland Clinic, Cleveland, OH.

Serpil C Erzurum (SC)

Lerner Research Institute (S.C.E.), Cleveland Clinic, Cleveland, OH.

Robert P Frantz (RP)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (R.P.F.).

Paul M Hassoun (PM)

Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD (P.M.H.).

Anna R Hemnes (AR)

Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN (A.R.H.).

Nicholas S Hill (NS)

Division of Pulmonary, Critical Care, and Sleep Medicine, Tufts Medical Center, Boston, MA (N.S.H.).

Evelyn M Horn (EM)

Division of Cardiology, Perkin Heart Failure Center, Weill Cornell Medicine, New York, NY (E.M.H.).

Jane A Leopold (JA)

Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (J.A.L.).

Erika B Rosenzweig (EB)

Department of Pediatrics and Medicine, Columbia University, Vegelos College of Physicians and Surgeons, New York, NY (E.B.R.).

W H Wilson Tang (WHW)

Department of Cardiovascular Medicine (D.H.K., M.M.P., W.H.W.T.), Cleveland Clinic, Cleveland, OH.

Jennifer D Wilcox (JD)

Department of Cardiovascular and Metabolic Sciences (J.D.W.), Cleveland Clinic, Cleveland, OH.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH